Skip to main content
SpringerLink
Log in

The Future: A Japanese Perspective

  • Chapter
IgA Nephropathy

Part of the book series: Topics in Renal Medicine ((TIRM,volume 2))

Abstract

IgA nephropathy is a distinct clinicopathologic entity originally described by Berger and Hinglais in 1968 [1]. IgA nephropathy (so-called Berger’s disease) is a more common type of glomerulonephritis in Japan than in France, the USA, and England [2–4]. Patients with IgA nephropathy account for more than 30% of patients with primary glomerulonephritis in Japan [4]. It is still unknown whether geographic and/or genetic factors are involved in the difference in the prevalence. Although IgA nephropathy is assumed to be an immune-complex-mediated glomerulonephritis, the antigens and exacerbating factors involved in this disease have not yet been identified. Moreover, there is no specific treatment of patients with IgA nephropathy. The purposes of this chapter are: (a) to describe the approach to pathogenesis and exacerbating factors, and (b) to describe the trials in new treatments for patients with IgA nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Berger J, Hinglais N: Les dépôts intercapillarés d’IgA-IgG. J Urol Nephrol 74:694–695, 1968.

    CAS  Google Scholar 

  2. Shirai T, Tomino Y, Sâto M, et al.: IgA nephropathy-Clinicopathology and immunopathology. Contrib Nephrol 9:88–100, 1978.

    PubMed  CAS  Google Scholar 

  3. D’Amico G: Idiopathic mesangial IgA nephropathy. In: Glomerular injury, 300 years after Morgagni. Bertani T, Remuzzi G (eds), Milan: Wichtig Editore, pp 205–228, 1983.

    Google Scholar 

  4. Kitajima T, Murakami M, Sakai O: Clinicopathological features in the Japanese patients with IgA nephropathy. Jpn J Med 22:219–222, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Moy RC, Abramowsky CR, Tisher CC: IgA nephropathy. Am J Pathol 76:123–144, 1974.

    Google Scholar 

  6. Lowance DC, Mullins JD, Mhaul JJ Jr: Immunoglobulin A (IgA) associated glomerulonephritis. Kidney Int 3:167–176, 1973.

    Article  PubMed  CAS  Google Scholar 

  7. Clarkson AR, Woodroffe AJ, Bannister KM, et al.: The syndrome of IgA nephropathy. Clin Nephrol 21:7–14, 1984.

    PubMed  CAS  Google Scholar 

  8. Tomino Y, Endoh M, Nomoto Y, et al.: Specificity of eluted antibody from renal tissues of patients with IgA nephropathy. Am J Kidney Dis 1:276–280, 1982.

    PubMed  CAS  Google Scholar 

  9. André C, Berthoux FC, André F, et al.: Prevalence of I2 deposits in IgA nephropathies: a clue to their pathogenesis. N Engl J Med 303:1343–1346, 1980.

    Article  PubMed  Google Scholar 

  10. Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin Al in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin Invest 66:1432–1436, 1980.

    Article  PubMed  CAS  Google Scholar 

  11. Tomino Y, Endoh M, Nomoto Y, et al.: Detection of immunoglobulin Al in kidney tissues from patients with IgA nephropathy. N Engl J Med 305:1159–1160, 1981.

    Article  PubMed  CAS  Google Scholar 

  12. Tomino Y, Miura M, Suga T, et al.: Detection of Il-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Nephron 37:137–139, 1985.

    Article  Google Scholar 

  13. Komatsu N, Nagura H, Watanabe K, et al.: Mesangial deposition of J chain-linked polymeric I in I nephropathy. Nephron 33:61–64, 1983.

    CAS  Google Scholar 

  14. Tomino Y, Sakai H, Miura M, et al.: Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 49:419–425, 1982.

    PubMed  CAS  Google Scholar 

  15. Bene M-C, Faure G, Duheille J: IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol 47:527–534, 1982.

    PubMed  CAS  Google Scholar 

  16. Valentijn RM, Radl J, Haayman JJ, et al.: Macromolecular IgA1 in the circulation and mesangial deposits in patients with primary IgA nephropathy. Contrib Nephrol 40:87–92, 1984.

    PubMed  CAS  Google Scholar 

  17. Sinniah R: IgA mesangial nephropathy: Berger’s disease. Am J Nephrol 5:73–83, 1985.

    Article  PubMed  CAS  Google Scholar 

  18. Woodroffe AJ, Gormly AA, Menzie PE, et al.: Immunologic studies in I nephropathy. Kidney Int 18:366–374, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Nagy J, Uj M, Szucs G, et al.: Herpes virus antigens and antibodies in kidney biopsies and sera of I glomerulonephritis. Clin Nephrol 21:259–262, 1984.

    PubMed  CAS  Google Scholar 

  20. Finlayson G, Alexander R, Juncos L, et al.: Immunoglobulin A glomerulonephritis: a clinicopathologic study. Lab Invest 32:140–148, 1975.

    PubMed  CAS  Google Scholar 

  21. Tomino Y, Endoh M, Kaneshige H, et al.: Increase of IgA in pharyngeal washings from patients with IgA nephropathy. Am J Med Sci 286:15–21, 1983.

    Article  PubMed  CAS  Google Scholar 

  22. Tomino Y, Sakai H, Endoh M, et al.: Cross-reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy. Clin Exp Immunol 51:605–610, 1983.

    PubMed  CAS  Google Scholar 

  23. Tomino Y, Sakai H, Miura M, et al.: Cytopathic effects of antigens in patients with IgA nephropathy. Nephron 42:161–166, 1986.

    Article  PubMed  CAS  Google Scholar 

  24. Tomino Y, Sakai H, Miura M, et al.: Detection of antigenic substances in patients with IgA nephropathy. Contrib Nephrol 40:69–73, 1984.

    PubMed  CAS  Google Scholar 

  25. Tomino Y, Sakai H, Miura M, et al.: Specific binding of circulating IgA antibodies in patients with IgA nephropathy. Am J Kidney Dis 6:149–153, 1986.

    Google Scholar 

  26. Nicholls K, Walker RG, DowlinP, et al.: “Malignant” I nephropathy. Am J Kidney Dis 5:42–46, 1985.

    PubMed  CAS  Google Scholar 

  27. Yoshida M, Ohn: Primary glomerular diseases in internal medicine [in Japanese], Pathol Clin Med 2:888–894, 1984.

    Google Scholar 

  28. Woo KT, Tan YO, Yap HK, et al.: Beta2-microglobulin in mesangial IgA nephropathy. Nephron 37:78–81, 1984.

    Article  PubMed  CAS  Google Scholar 

  29. Sato M, Morikawa K, Koshikawa S: Attachment of polymorphonuclear leukocytes to glomeruli in IgA nephropathy. Clin Immunol Immunopathol 29:111–118, 1983.

    Article  PubMed  CAS  Google Scholar 

  30. Tomino Y: Complement system in IgA nephropathy. Toka Exp Clin Med 5:15–22, 1980.

    CAS  Google Scholar 

  31. Tomino Y, Sakai H, Suga T, et al.: Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. Am J Kidney Dis 3:48–53, 1983.

    PubMed  CAS  Google Scholar 

  32. Miura M, Tomino, Endoh M, et al.: Immunofluorescent studies on alpha 2-plasmin inhibitor (α2-PI) in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 62:380–386, 1985.

    PubMed  CAS  Google Scholar 

  33. Clarkson AR, Woodroffe AJ: Therapeutic perspectives in mesangial IgA nephropathy. Contrib Nephrol 40:187–194, 1984.

    PubMed  CAS  Google Scholar 

  34. Kurokawa K, Yoshida M, Sakai O, et al.: IgA nephropathy in Japan. Am J Nephrol 5:127–137, 1985.

    Article  PubMed  Google Scholar 

  35. Tomino Y, Miura M, Suga T, et al.: Defibrination of intraglomerular fibrin deposits by urokinase in patients with I nephropathy. Jpn J Nephrol 26:275–280, 1984.

    CAS  Google Scholar 

  36. Tomino Y, Miura M, Suga T, et al.: Effects of a “single shot” of urokinase on fibrinolytic activities in patients with IgA nephropathy. Tokai J Exp Clin Med 9:43–47, 1984.

    PubMed  CAS  Google Scholar 

  37. Tomino Y, Sakai H, Miura M, et al.: Effects of danazol on solubilization activities of immune deposits in patients with IgA nephropathy. Am J Kidney Dis 4:135–140, 1984.

    PubMed  CAS  Google Scholar 

  38. Miura M, Tomino Y, Yagame M, et al.: Significant correlation between the immunofluorescence of alpha 2-plasmin inhibitor in glomeruli and the effects of urokinase therapy in patients with IgA nephropathy. Annals Academy of Medicine 15:255–257, 1986.

    CAS  Google Scholar 

  39. Miller GW, Nussenzweig, V.: A new complement function: solubilization of antigen- antibody aggregates. Proc Natl Acad Sci USA 72:418–422, 1975.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Yasuhiko Tomino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Anthony R. Clarkson

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Tomino, Y. (1987). The Future: A Japanese Perspective. In: Clarkson, A.R. (eds) IgA Nephropathy. Topics in Renal Medicine, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2039-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2039-5_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9213-5

  • Online ISBN: 978-1-4613-2039-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation